ESC Professional Premium Access

The clinically active PARP inhibitor olaparib ameliorates doxorubicin-induced cardiotoxicity in both in vitro and in vivo model

Topic: Drugs, Drug Targets

Congress Presentation

About the speaker

Ms Dongqing Chen

University of Newcastle, Newcastle (Australia)
0 follower

5 more presentations in this session

Heart failure stimulates colorectal tumour growth through gut microbial alterations of specific populations

Speaker: Ms S. De Wit (Groningen, NL)


Cardiometabolic rewiring in the context of doxorubicin-induced cardiotoxicity: fuel preference changes from fatty acids to glucose oxidation

Speaker: Doctor G. Guerra (Turin, IT)


Rapamycin ameliorates doxorubicin-induced cardiomyopathy through suppression of RIPK1-independent necroptosis

Speaker: Doctor M. Shimizu (Sapporo, JP)


CaMKIIdelta-mediated SR Ca leak contributes to long-term Doxorubicin-induced cardiotoxicity

Speaker: Miss A. Feder (DE)


Glycogen Synthase Kinase 3 beta confers refractoriness to the microRNA-210-elicited exacerbation of hypoxia-reoxygenation stress-induced apoptotic cell death

Speaker: Doctor G. Marwarha (Trondheim, NO)


Access the full session

Molecular cardio-oncology

Speakers: Ms D. Chen, Ms S. De Wit, Doctor G. Guerra, Doctor M. Shimizu, Miss A. Feder...

About the event


ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb